- cafead   Sep 12, 2024 at 10:42: AM
via After an initial defeat against the biggest barrier to mRNA flu vaccines—namely, B strains of influenza—GSK has returned with a reformulated candidate that has delivered the goods in the all-important population of older adults.
article source
article source